CVC continues Evonik sell-down with €700m placement
CVC Capital Partners has sold a 4.7% stake in German chemicals group Evonik at €31.85 a share, worth around €700m.
More on Industrials
Actera Group explores strategic options for Celebi Ground Handling
Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal
Felss Group backer Capvis lines up PwC to guide sale process
Sale of German cold-forming specalist is under way, six and a half years into GP's holding period
CMA scrutiny of high-leverage PE divestment purchases expected to increase
PE could stand to lose its historic advantage with heightened regulatory baggage
Evoco expects portfolio acquisitions, assesses potential exits in 2H23
Switzerland-headquartered GP is currently deploying equity via its EUR 162m Evoco TSE III fund
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater